Ebola Bundibugyo Vaccines in Development Four Months Before Outbreak
An Ebola outbreak in the Ituri province of the Democratic Republic of the Congo (DRC) was confirmed by the Africa Centers for Disease Control and Prevention (Africa CDC) on May 15, 2026. Through laboratory analysis, health officials confirmed that the outbreak is caused by the Bundibugyo ebola strain, for which there is no vaccine currently […]
Novavax Expands Matrix-M Adjuvant Deals Through Partnership With Sanofi
Novavax, Inc. of Gaithersburg, Maryland is continuing to move away from relying primarily on direct vaccine sales and is instead focusing more heavily on licensing agreements and corporate partnerships. The company recently expanded deals with pharmaceutical giants Pfizer, Inc. and Sanofi SA as it attempts to build a more stable revenue stream following a sharp […]
Medical Journals Publishing Tens of Thousands of Fake Scientific Papers
Medical journals are increasingly riddled with fake scientific papers put out by “paper mills”—profit-oriented organizations that produce and sell fabricated manuscripts or ones containing manipulated scientific data. In the past year, approximately 70,000 (1.5 – 2 percent) of published scientific papers were generated by paper mills. It is estimated that, over the last two decades, […]
Malaria Confirmed in States Where Gates’ Funded Company Released Millions of Mosquitos
A new potentially manufactured health crisis is on the horizon—just in time for a malaria vaccine funded by Bill Gates to hit the market and what seems like minutes after a Gates-funded company released millions of genetically modified mosquitos into the same states where cases occurred. According to the Centers for Disease Control and Prevention, five cases of malaria—four […]
Pfizer Wants to Use Children in COVID-19 Vaccine Clinical Trial
On Oct. 14, 2020, Pfizer, Inc. of New York City, New York announced it had received approval by the U.S. Food and Drug Administration (FDA) to enroll children in the Phase 3 human clinical trial on its experimental messenger RNA (ribonucleic acid) BNT162b1 vaccine for COVID-19. The trial, which last month was expanded to include adolescent […]
How Will Unhealthy Americans React to COVID-19 Vaccines?
If you look at the human clinical trials that have been conducted this year by drug companies developing experimental vaccines for COVID-19, the participants in those trials have all been “healthy adults.” Take, for example, Moderna’s Phase 1 clinical trial for its mRNA-1273 vaccine, which included 45 healthy adults 18 to 55 years old. The same […]